Paper Report for: London_1995_Eur.J.Pharmacol_278_R1
Reference
Title: In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine London ED, Scheffel U, Kimes AS, Kellar KJ Ref: European Journal of Pharmacology, 278:R1, 1995 : PubMed
In vivo imaging of nicotinic acetylcholine receptors in brain has been hampered by lack of an adequate radioligand. In the present study, [3H]epibatidine was administered to mice intravenously, and its time-course in brain regions and sensitivity to blockade by nicotinic drugs were studied. The distribution of radioligand accumulation in brain, and the pharmacological characteristics of binding indicate that radiolabeled forms of epibatidine would be exceptionally promising ligands for the study of nicotinic acetylcholine receptors in vivo.
        
Related information
Citations formats
London ED, Scheffel U, Kimes AS, Kellar KJ (1995) In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine European Journal of Pharmacology278: R1-2
London ED, Scheffel U, Kimes AS, Kellar KJ (1995) European Journal of Pharmacology278: R1-2